Skip to content

A first-in-human study to learn about how safe the study drug is in healthy participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517512-30-00
Acronym
22819
Enrollment
210
Registered
2025-03-21
Start date
2025-04-28
Completion date
2025-11-24
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac arrhythmia

Interventions

None listed

Sponsors

Bayer AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026